The New England Journal of Medicine.
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
The New England Journal of Medicine.
Jun 25, 2024, 14:38 |
Insight
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results …
Jun 7, 2024, 10:36 |
Insight
Vincent Rajkumar: I’m updating my 2024 Review on myeloma for American Journal of Hematology
Vincent Rajkumar shared a post on X: “I’m updating my 2024 Review on myeloma for American…
Jun 7, 2024, 08:23 |
Blog
Myriam Chalabi: The results of the NICHE-2 study now published in NEJM
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, shared a post…
May 1, 2024, 00:59 |
Insight
Angela Mastronuzzi: Yet another impactful and giant step in clinical research
Angela Mastronuzzi shared on LinkedIn: "Also out with The NEW ENGLAND JOURNAL of MEDICINE of the NEJM Group:…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Mar 8, 2024, 19:12 |
Drugs
Naveen Pemmaraju: Rusfertide for patients with phlebotomy-dependent Polycythemia Vera (PV)
Naveen Pemmaraju posted on LinkedIn: ''Honored to share our brand new paper recently published in…
Nov 23, 2023, 15:44 |
Blog
Chandler Park: We FINALLY have an effective FDA approved practice changing treatment for OUR patients that have a rising PSA after radical prostatectomy and/or radiation treatment
Oct 27, 2023, 04:23 |
Insight
The first randomised trial of a targeted agent versus immunotherapy plus chemotherapy in a biomarker-selected patient population - CUHK Medicine
CUHK Medicine shared on LinkedIn: " More than doubled lung cancer patients’ progression-free survival Lung…
All:
8
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube